Design for manufacturing of class IIb medical devices with risk-based approach

Design for Manufacturing (DfM) for Class IIb medical devices requires structured regulatory compliance, lifecycle risk management, process capability engineering, and digital traceability. Class IIb devices require a high degree of confidence in safety and performance during development, scale-up, and commercial production because of prolonged patient contact or life-sustaining functions. Current regulatory developments, especially the European Union Medical Device Regulation (EU MDR), have greatly increased the expectations regarding clinical evidence, post-market surveillance, and risk management integration. At the same time, digital manufacturing transformation, such as smart manufacturing and Industry 4.0 architectures, have added new opportunities and complexities to ensuring validated risk-controlled production systems. The existing literature points to ongoing disconnection between design intent and manufacturing implementation, in particular, design transfer, software-controlled device control, and lifecycle data integration. Recent studies indicate that proactive risk reduction in a regulated setting can be aided with the help of predictive analytics, model-based systems engineering (MBSE), and AI-based quality monitoring. Nevertheless, unified models that match DfM, risk management standards, and digital lifecycle infrastructure have not been developed yet. This review brings together regulatory precepts, risk-based engineering approaches, manufacturability schemes, and ideas of digital integration that are peculiar to Class IIb products. It suggests organized life cycle integration models which relate design controls, risk control allocation, process validation, and post-market intelligence. The analysis shows that risk-informed DfM that is incorporated early in the development process can significantly improve process capability, minimize nonconformities, and decrease recall exposure.